Literature DB >> 20016532

Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD).

S Abbas, C A J Erpelinck-Verschueren, C S Goudswaard, B Löwenberg, P J M Valk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20016532     DOI： 10.1038/leu.2009.265

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

Review 1.  Epigenetic regulators and their impact on therapy in acute myeloid leukemia.

Authors:  Friederike Pastore; Ross L Levine
Journal:  Haematologica       Date:  2016-03       Impact factor: 9.941

2.  Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.

Authors:  Sanjai Sharma; Wei Liao; Xiaofeng Zhou; David T W Wong; Alan Lichtenstein
Journal:  Mol Cancer Ther       Date:  2011-07-15       Impact factor: 6.261

3.  The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.

Authors:  Vincent Mocquet; Julia Neusiedler; Francesca Rende; David Cluet; Jean-Philippe Robin; Jean-Michel Terme; Madeleine Duc Dodon; Jürgen Wittmann; Christelle Morris; Hervé Le Hir; Vincenzo Ciminale; Pierre Jalinot
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

Review 4.  Mechanisms that regulate the activities of TET proteins.

Authors:  Kanak Joshi; Shanhui Liu; Peter Breslin S J; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-15       Impact factor: 9.207

Review 5.  Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia.

Authors:  Raajit Rampal; Maria E Figueroa
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

6.  Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer.

Authors:  Wei Liao; Gwen Jordaan; Minu K Srivastava; Steven Dubinett; Sherven Sharma; Sanjai Sharma
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

7.  WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia.

Authors:  Fulvio Bordin; Erich Piovan; Elena Masiero; Alberto Ambesi-Impiombato; Sonia Minuzzo; Roberta Bertorelle; Valeria Sacchetto; Giorgia Pilotto; Giuseppe Basso; Paola Zanovello; Alberto Amadori; Valeria Tosello
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

8.  The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients.

Authors:  Sergiu Pasca; Cristina Turcas; Ancuta Jurj; Patric Teodorescu; Sabina Iluta; Ionut Hotea; Anca Bojan; Cristina Selicean; Bogdan Fetica; Bobe Petrushev; Vlad Moisoiu; Alina-Andreea Zimta; Valentina Sas; Catalin Constantinescu; Mihnea Zdrenghea; Delia Dima; Ciprian Tomuleasa
Journal:  Diagnostics (Basel)       Date:  2020-04-29

9.  DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.

Authors:  Raajit Rampal; Altuna Alkalin; Jozef Madzo; Aparna Vasanthakumar; Elodie Pronier; Jay Patel; Yushan Li; Jihae Ahn; Omar Abdel-Wahab; Alan Shih; Chao Lu; Patrick S Ward; Jennifer J Tsai; Todd Hricik; Valeria Tosello; Jacob E Tallman; Xinyang Zhao; Danette Daniels; Qing Dai; Luisa Ciminio; Iannis Aifantis; Chuan He; Francois Fuks; Martin S Tallman; Adolfo Ferrando; Stephen Nimer; Elisabeth Paietta; Craig B Thompson; Jonathan D Licht; Christopher E Mason; Lucy A Godley; Ari Melnick; Maria E Figueroa; Ross L Levine
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

Review 10.  Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.

Authors:  Cristina Panuzzo; Elisabetta Signorino; Chiara Calabrese; Muhammad Shahzad Ali; Jessica Petiti; Enrico Bracco; Daniela Cilloni
Journal:  J Clin Med       Date:  2020-03-16       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.